Study to Monitor the Incidence of Pure Red Cell Aplasia (PRCA) and/or Antibodies to Erythropoietin Among Participants Receiving Epoetin Alfa or Another Erythropoietin

Clinical trial NCT00210951 · COMPLETED

Trial details

NCT number: NCT00210951
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Study type: OBSERVATIONAL

Red-Cell Aplasia, Pure Chronic Renal Failure

Start date: 2003-05-01
Primary completion: 2005-07-01
Enrollment: 4761

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.